Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2025 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

clover health investments corp - CLOV

CLOV

Close Chg Chg %
2.62 0.04 1.53%

Pre-Market

2.66

+0.04 (1.53%)

Volume: 4.74M

Last Updated:

Dec 4, 2025, 4:00 PM EDT

Trade Now

Company Overview: clover health investments corp - CLOV

CLOV Key Data

Open

$2.61

 Day Range

2.58 - 2.72

52 Week Range

2.12 - 4.86

 Market Cap

$1.35B

Shares Outstanding

516.68M

 Public Float

390.98M

Beta

2.25

 Rev. Per Employee

N/A

P/E Ratio

N/A

 EPS

-$0.12

Yield

0.00%

 Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

6.90M

  

CLOV Performance

1 Week
 
 6.83%
 
1 Month
 
 -0.37%
 
3 Months
 
 -3.27%
 
1 Year
 
 -20.83%
 
5 Years
 
 -74.69%
 

CLOV Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 3
Full Ratings ➔

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 3.367
Number of Ratings 3 Current Quarters Estimate -0.103
FY Report Date 12 / 2025 Current Year's Estimate -0.174
Last Quarter’s Earnings -0.05 Median PE on CY Estimate N/A
Year Ago Earnings -0.09 Next Fiscal Year Estimate -0.025
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 3 3 3 3
Mean Estimate -0.10 0.01 -0.17 -0.03
High Estimates -0.10 0.03 -0.17 0.02
Low Estimate -0.11 -0.04 -0.18 -0.06
Coefficient of Variance -6.62 601.55 -3.25 -172.94

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 1 1 2
OVERWEIGHT 0 0 0
HOLD 2 2 2
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Overweight Overweight Overweight

Insider Actions for Clover Health Investments Corp - CLOV

Date Name Shares Transaction Value
Aug 13, 2025 Andrew Toy Chief Executive Officer; Director 10,474,512 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $2.18 per share 22,834,436.16
Apr 8, 2025 Jamie L. Reynoso CEO, Medicare Advantage 3,263,768 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $3.51 per share 11,455,825.68
Mar 12, 2025 Carladenise Armbrister Edwards Director 273,227 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $3.61 per share 986,349.47
Feb 20, 2025 Karen M. Soares General Counsel & Secretary 1,352,163 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $4.46 per share 6,030,646.98

Clover Health Investments Corp in the News